Oramed Pharmaceuticals Inc. (the "Company) (OTCBB: ORMP) is proud to announce the heavily anticipated application for final approval allowing the phase 1 clinical studies on healthy volunteers has been sent and successfully granted by the Israeli Ministry of Health. The Ministry of Health is responsible for supervising, monitoring, and regulating the pharmaceuticals sector, by licensing medicinal preparations and setting standards for medicinal and cosmetic preparations, as well as for toxic substances, among many other services for the public.
